Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-05-20 | New | $4,680,000 | $4,680,000 | Equity Only | 06b | SEC link |
| 2021-11-30 | New | $4,000,000 | $4,000,000 | Equity Only | 06b | SEC link |
| 2020-08-19 | New | $250,000 | $250,000 | Equity Only | 06b | SEC link |
| 2019-09-25 | New | $5,445,599 | $5,445,599 | Equity Only | 06b | SEC link |
| 2017-04-07 | New | $35,000,065 | $35,000,065 | Equity Only | 06b | SEC link |
| 2015-10-13 | New | $15,000,000 | $15,000,000 | Equity and Debt | 06b | SEC link |
| 2015-10-13 | Amended | $34,999,943 | $4,999,971 | Equity Only | 06b | SEC link |
| 2014-08-04 | New | $29,999,972 | $29,999,972 | Equity Only | 06b | SEC link |
| 2010-06-21 | New | $21,055,999 | $21,055,999 | Equity Only | 06 | SEC link |
| Name | Role |
|---|---|
| Henrik Bruun Andersen | Executive |
| Eric Bednarski | Director |
| Victor M. Clavelli | Executive |
| Klaas De Boer | Director |
| Kyle Dempsey | Director |
| Helena Kyttari Djupesland | Executive |
| Per Djupesland | Director |
| William F. Doyle | Director |
| R. John Fletcher | Director |
| Tom Gibbs | Executive |
| Keith A. Goldan | Executive |
| Wilhelmus Groenhuysen | Director |
| Sandra L. Helton | Director |
| Tomas J. Heyman | Director |
| Michele Janis | Executive |
| Anthony J. Krick | Executive |
| Ramy A. Mahmoud | Director, Executive |
| Michael F. Marino | Executive |
| Peter K. Miller | Director, Executive |
| Robert P. O'neil | Director |
| Patrick O'neill | Director |
| Catherine E. Owen | Director |
| Jackson Phillips | Director |
| Larry Pickering | Director |
| Joseph C. Scodari | Director |
| Paul Spence | Executive |
| Joshua A. Tamaroff | Director |
| Terrence Terifay | Executive |
| Sriram Venkataraman | Director |